Interferon Beta
Overview
Interferons are potent cytokines that possess antiviral, immunomodulating and antiproliferative actions. The interferones bind to specific cell-surface receptors that initiate a series of intracellular events, induction of certain enzymes, inhibition of cell-proliferation, and enhancement of immune activities. It (IFNB) is a type of interferon produced by fibroblasts and epithelial cells. The term "it" used here encompasses products that are further differentiated as either it-1a or it-1b. it-I a, a 166-amino acid recombinant glycoprotein, and it-I b, a 165-amino acid recombinant protein, used in the treatment of multiple sclerosisto reduce the frequency of clinical exacerbations.
Categories
- 8 Antineoplastics, immunomodulators and drugs used in palliative care
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Interferon Beta's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 0.25 mg | 0.25 (0.25) | As recommended. | SC | Should be injected every other day. Generally, patients should be started at 0.0625 mg (0.25 mL) subcutaneously every other day, and increased over a six week period to 0.25 mg (1.0 mL) every other day |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Interferon Beta is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Interferon Beta is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Interferon Beta
Back to top
Manufacturers of
Interferon Beta
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic